Endra Life Sciences Inc.
13F holders, Q2 2024 (June 30)17holders +4
9new positions
5sold out
$0.10avg. 13F price*
At the end of Q2 2024, 17 institutions reported holding Endra Life Sciences Inc. in their 13F filings, up 4 from Q1 2024. 9 opened new positions and 5 sold out. The largest holders were HRT Financial LP ($32K), Jane Street Group, LLC ($11K) and Geode Capital Management, LLC ($7K).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B302
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $44K |
| Exits | 5 | $48K |
All 13F filers, Q1 2024 → Q2 2024: 650,035 shares bought and 83,921 shares sold, net +566,114 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| HRT Financial LP | 0.00% | New | 329,571 | $32K |
| Jane Street Group, LLC | 0.00% | Add +223.7% | 116,914 | $11K |
| Geode Capital Management, LLC | 0.00% | Add +40.4% | 76,171 | $7K |
| UBS Group AG | 0.00% | Add +39509.3% | 55,453 | $5K |
| Vanguard Group Inc. | 0.00% | No change | 39,812 | $4K |
| Susquehanna International Group, LLP | 0.00% | New | 37,838 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +293.0% | 34,020 | $3K |
| NewEdge Advisors, LLC | 0.00% | Reduce -3.1% | 29,985 | $3K |
| Kestra Advisory Services, LLC | 0.00% | New | 22,500 | $2K |
| StoneX Group Inc. | 0.00% | New | 16,766 | $2K |
| Sassicaia Capital Advisers LLC | 0.01% | New | 16,000 | $2K |
| Brevan Howard Capital Management LP | 0.00% | New | 15,991 | $2K |
| XTX Topco Ltd | 0.00% | Add +38.1% | 14,853 | $1K |
| Marex Group Ltd | 0.00% | New | 12,800 | $1K |
| Morgan Stanley | 0.00% | Add +3012.1% | 10,332 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 1,000 | $97 |
| Bank of America Corp. | 0.00% | New | 69 | $7 |
"% of holder's portfolio" is ENDRA LIFE SCIENCES INC's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.